BCG vaccine derived peptides induce SARS-CoV-2 T cell cross-reactivity
View ORCID ProfilePeter J. Eggenhuizen, Boaz H. Ng, Janet Chang, Ashleigh L. Fell, Wey Y. Wong, Poh- Yi Gan, Stephen R. Holdsworth, Joshua D. Ooi
doi: https://doi.org/10.1101/2020.11.21.20236018
Peter J. Eggenhuizen
1Centre for Inflammatory Diseases, Dept. of Medicine Monash Medical Centre, School of Clinical Sciences, Monash University, Clayton, Victoria 3168 Australia
Boaz H. Ng
1Centre for Inflammatory Diseases, Dept. of Medicine Monash Medical Centre, School of Clinical Sciences, Monash University, Clayton, Victoria 3168 Australia
Janet Chang
1Centre for Inflammatory Diseases, Dept. of Medicine Monash Medical Centre, School of Clinical Sciences, Monash University, Clayton, Victoria 3168 Australia
Ashleigh L. Fell
1Centre for Inflammatory Diseases, Dept. of Medicine Monash Medical Centre, School of Clinical Sciences, Monash University, Clayton, Victoria 3168 Australia
Wey Y. Wong
1Centre for Inflammatory Diseases, Dept. of Medicine Monash Medical Centre, School of Clinical Sciences, Monash University, Clayton, Victoria 3168 Australia
Poh- Yi Gan
1Centre for Inflammatory Diseases, Dept. of Medicine Monash Medical Centre, School of Clinical Sciences, Monash University, Clayton, Victoria 3168 Australia
2Dept. of Immunology, Monash Health, Monash Medical Centre, Clayton, Victoria 3168 Australia
Stephen R. Holdsworth
1Centre for Inflammatory Diseases, Dept. of Medicine Monash Medical Centre, School of Clinical Sciences, Monash University, Clayton, Victoria 3168 Australia
2Dept. of Immunology, Monash Health, Monash Medical Centre, Clayton, Victoria 3168 Australia
Joshua D. Ooi
1Centre for Inflammatory Diseases, Dept. of Medicine Monash Medical Centre, School of Clinical Sciences, Monash University, Clayton, Victoria 3168 Australia
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Posted November 23, 2020.
BCG vaccine derived peptides induce SARS-CoV-2 T cell cross-reactivity
Peter J. Eggenhuizen, Boaz H. Ng, Janet Chang, Ashleigh L. Fell, Wey Y. Wong, Poh- Yi Gan, Stephen R. Holdsworth, Joshua D. Ooi
medRxiv 2020.11.21.20236018; doi: https://doi.org/10.1101/2020.11.21.20236018
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2318)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11653)
- Forensic Medicine (10)
- Gastroenterology (688)
- Genetic and Genomic Medicine (3656)
- Geriatric Medicine (344)
- Health Economics (625)
- Health Informatics (2341)
- Health Policy (922)
- Hematology (337)
- HIV/AIDS (765)
- Medical Education (362)
- Medical Ethics (102)
- Nephrology (394)
- Neurology (3407)
- Nursing (193)
- Nutrition (512)
- Oncology (1788)
- Ophthalmology (529)
- Orthopedics (212)
- Otolaryngology (284)
- Pain Medicine (227)
- Palliative Medicine (66)
- Pathology (442)
- Pediatrics (1015)
- Primary Care Research (411)
- Public and Global Health (6047)
- Radiology and Imaging (1243)
- Respiratory Medicine (816)
- Rheumatology (373)
- Sports Medicine (319)
- Surgery (392)
- Toxicology (50)
- Transplantation (171)
- Urology (144)